Matthew Harris
Förmögenhet: 28 M $ per 2026-07-31
Förmögenhet: 28 M $ per 2026-07-31
Matthew Harris is the founder and the Chief Scientific Officer of Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer of Gateway Capital Ltd. and a Non-Executive Director at Genera Biosystems Ltd. from 2007 to 2008.
Dr. Harris holds a doctorate from The Australian National University and an MBA from the Australian Graduate School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-08-22 | 16 699 842 ( 4,48 % ) | 28 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Grundare | 2010-01-01 |
| Företag | Position | Slut |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Direktör/Styrelseledamot | 2008-12-12 |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | President | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Finance |
Genera Biosystems Ltd.
Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Manufactures, develops and commercializes multiplexed molecular diagnostic tests | Health Technology |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån